Abstract:Adipose tissues are the major organ that controls systemic energy metabolism and maintain homeostasis. There are two major classes of adipocytes. White adipocytes store and release lipids, while brown adipocytes generate heat by uncoupling oxidative phosphorylation through the action of mitochondrial uncoupling protein 1. In addition, cold exposure and β3 stimulation induce development of brown cell-like "beige" adipocytes in white adipose tissues. Brown adipose tissue and/or beige fat-mediated thermogenesis suppresses high-fat-diet-associated obesity in mice. Therefore, there is great expectation that brown/beige fat activity can be increased to reduce obesity and metabolic disease. Fibroblast growth factor 21 (FGF21) is an important metabolic regulator of glucose and lipid homeostasis, and is expressed in multiple tissues including liver, pancreas, white and brown adipose tissues, and skeletal muscle. In addition, FGF21 is being pursued as a therapeutic target for diabetes and obesity because of its benefits in regulating glucose and lipid metabolism. In this study, a total of 88 crude herbal drugs frequently used in Kampo prescriptions (traditional Japanese medicine) were selected and screened for up-regulation of expression of FGF21 in beige adipocytes. As a result, we found that berberine, an isoquinoline alkaloid, significantly increased FGF21 expression in brown and beige adipocytes. Furthermore, we investigated the target molecule of berberine in regulation of the FGF21 expression in beige adipocytes. To address this, total RNA was extracted from in beige adipocytes after exposure to berberine, and analyzed by real time qRT-PCR. We found the expression of FGF21 mRNA was significantly increased by berberine in beige adipocytes. Additionally, the up-regulation of FGF21 mRNA by berberine was completely abolished by an AMP-activated kinase (AMPK) inhibitor, compound C, in beige adipocytes. These findings suggested that berberine stimulated FGF21 expression through activation of AMPK signaling pathway in brown and beige adipocytes.

Identification of berberine as a novel agonist of fatty acid receptor GPR40

Berberine is an insulin secretagogue targeting the KCNH6 potassium channel

Berberine Ameliorates High-fat-induced Insulin Resistance in HepG2 Cells by Modulating PPARs Signaling Pathway

Effects and mechanisms of berberine in diabetes treatment

Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis.

Structural modification of berberine alkaloid and their hypoglycemic activity

Chronic Effects of Berberine on Blood, Liver Glucolipid Metabolism and Liver PPARs Expression in Diabetic Hyperlipidemic Rats

Berberine promotes glucose consumption independently of AMP-activated protein kinase activation

Berberine Lowers Blood Glucose in Type 2 Diabetes Mellitus Patients Through Increasing Insulin Receptor Expression

Berberine Metabolites Stimulate GLP-1 Secretion by Alleviating Oxidative Stress and Mitochondrial Dysfunction

Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron

Novel Phenoxyalkanoic Acid Derivatives as Free Fatty Acid Receptor 4 Agonists for Treating Type 2 Diabetes Mellitus

Berberine improves glucose metabolism through induction of glycolysis

Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold.

Lipid receptors and islet function: therapeutic implications?

Fatty acid receptors as new therapeutic targets for diabetes

Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine

Berberine stimulates FGF21 expression via activation of AMP-activated protein kinase in brown and beige adipocytes

Selective Small-Molecule Agonists of G Protein–Coupled Receptor 40 Promote Glucose-Dependent Insulin Secretion and Reduce Blood Glucose in Mice

Berberine Promotes Glucose Uptake and Inhibits Gluconeogenesis by Inhibiting Deacetylase SIRT3

Insulin-Mimetic Activity of Herbal Extracts Identified with Large-Scale Total Internal Reflection Fluorescence Microscopy